Delivery Order SPE2DB24D1205-SPE2DB25FCRHG
Award Date
11/1/24
Potential Completion Date
11/4/24
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,555.45 delivery order is for the supply of KISQALI 400 MG DAILY DOSE 42S, a specialty medication. The contract has a firm fixed-price pricing type and an ultimate completion date of December 18, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999...
This federal contract award, SPE2DB22D3009|SPE2DB25FAR55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,895.64 Firm Fixed Price Delivery Order contract is for the supply of KISQALI 600 MG DAILY DOSE 63S, a medication. The contract has an ultimate completion date of February 19, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with an ID of SPE2DB22D3009|SPE2DB24FBA52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,387.19 firm fixed-price delivery order is for the supply of KISQALI 600 MG DAILY DOSE 63S, a pharmaceutical product. The contract has an ultimate completion date of July 15, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,078.22 firm fixed price delivery order is for KISQALI 600 MG DAILY DOSE 63S, a pharmaceutical product. The contract has an ultimate completion date of January 23, 2025. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $21,362.48, is for the delivery of the medication KISQALI 600 MG DAILY DOSE 63S. This is a Firm Fixed Price delivery order contract with a completion date of June 13, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999...
This federal contract award, valued at $43,995.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for 4,567,968,370 units of the drug KISQALI 600 MG DAILY DOSE 63S. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $26,443.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication KISQALI 600 mg daily dose, 63s, with a completion date of January 6, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $39,332.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the drug KISQALI 600 MG DAILY DOSE 63S, with a period of performance through December 19, 2024. The award was made without a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,846.54 firm fixed price delivery order is for the supply of Kisqali 600 mg daily dose medication. The contract has an ultimate completion date of June 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $14,077.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of November 6, 2023. The award is for the delivery of KISQALI 400 MG DAILY DOSE 42S, a pharmaceutical product. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...